The frequencies of BRAF V600 and NRAS Q61 mutations were evaluated in 267 FFPE melanoma patients of the series (flow chart in Additional file 2: Figure S2) diagnosed between March 2013 and May 2015. The gene discussed is NRAS; the disease is melanoma.